Amgen (AMGN) Q1 2026 Earnings Beat EPS Forecast

Published on 5/9/2026

AI Summary

Summarized by AI from the source below

Amgen (AMGN) reported its Q1 2026 earnings, exceeding EPS forecasts. The company achieved earnings of $XYZ per share, surpassing analysts' expectations. Despite the earnings beat, AMGN's stock experienced a dip of X% following the announcement. This reaction may reflect investor concerns about future performance or guidance. The report suggests mixed sentiment among investors regarding Amgen's prospects.

Source: Read original article

Get the free market brief

Top stories and analysis, summarized. No spam, unsubscribe anytime.

Amgen (AMGN) Q1 2026 Earnings Beat EPS Forecast

AI Summary

Related News

Cardinal Health Raises Price Target After Positive Profit Guidance

Hnit-Baltic Uab Announcement: Financial Performance Updates

Travere Therapeutics (TVTX) Expands Focus on Rare Disease Treatments

Amazon (AMZN) Shares: Jeff Bezos Sells Over $4 Billion Worth